Clinical trial

A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3720 Tablets

NCT04853498

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2021-06-09

PhasePHASE1

Study timeline

Study start (actual)2021-06-09Date precision: day

Registry last updated2026-03-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Castration-resistant Prostate Cancerunresolved

Interventions

TQB3720DRUG

Sponsors & collaborators

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.lead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04853498 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.